Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.

Abstract

Etofibrate is a hypolipemic drug belonging to the fibrate class. By improving the lipid profile, these drugs often exert a favorable influence on hemostatic risk factors of ischemic heart disease. We present a pilot study on the influence of etofibrate on lipids and lipoproteins in serum, as well as on factor VII and fibrinogen. The study group was… (More)

Topics

Cite this paper

@article{Jastrzbska1999EtofibrateDF, title={Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.}, author={Małgorzata Jastrzębska and Barbara Torbus-Lisiecka and J Pieczul-Mr{\'o}z and K. Chelstowski and J Kopciewicz and Michal Naruszewicz}, journal={International journal of clinical pharmacology research}, year={1999}, volume={19 1}, pages={19-25} }